A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Clinical trial NCT05538624 · TERMINATED

Trial details

NCT number: NCT05538624
Sponsor: Avenge Bio, Inc
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasm, Ovarian Fallopian Tube Cancer Primary Peritoneal Cavity Cancer Adenocarcinoma Ovary Serous Adenocarcinoma of Ovary Serous Adenocarcinoma of Primary Peritoneum Primary Peritoneal Carcinoma High Grade Serous Adenocarcinoma

Start date: 2022-12-09
Primary completion: 2024-04-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.